Ticker
SLRX
Price Target
Refer to Report
Volume
700
52wk Range
$0.5148 - $108
Overview
Salarius Pharmaceuticals Inc is a biotechnology company developing targeted therapies to treat pediatric and other cancers, including advanced solid tumors. Its lead compound Seclidemstat is in clinical development for treating Ewing sarcoma.
Other Considerations
Company
Ticker
Price
Previous
Mkt Cap
Volume
52wk Range
Company
Ticker
Price
Previous
Mkt Cap
Volume
52wk Range
Company
Ticker
Price
Previous
Mkt Cap
Volume
52wk Range
Company
Ticker
Price
Previous
Mkt Cap
Volume
52wk Range
Company
Ticker
Price
Previous
Mkt Cap
Volume
52wk Range
Company
Ticker
Price
Previous
Mkt Cap
Volume
52wk Range
Company
Ticker
Price
Previous
Mkt Cap
Volume
52wk Range
Company
Ticker
Price
Previous
Mkt Cap
Volume
52wk Range
Company
Ticker
Price
Previous
Mkt Cap
Volume
52wk Range
Company
Ticker
Price
Previous
Mkt Cap
Volume
52wk Range
Inbox Intel from Channelchek.
Informed investors make more money. And it’s all about timing. Get it when it happens.